Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8817944 | Health Policy | 2018 | 5 Pages |
Abstract
Given payer expectations, pharmaceutical companies should continue to take a role in ensuring that they have sufficient capacity to support payers in the design and implementation of innovative pricing agreements.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
William C.N. Dunlop, Alexandra Staufer, Pierre Levy, Guy J. Edwards,